Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
333.21M | 367.81M | 397.09M | 357.24M | 302.91M | 339.97M | Gross Profit |
161.35M | 217.81M | 244.71M | 251.83M | 216.49M | 250.70M | EBIT |
46.91M | 45.43M | 43.88M | 20.83M | 9.44M | 32.12M | EBITDA |
58.28M | 54.55M | 82.65M | 38.56M | 31.81M | 56.06M | Net Income Common Stockholders |
22.56M | 16.72M | 21.51M | 12.30M | -8.62M | 13.21M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
356.41M | 356.41M | 286.44M | 330.23M | 227.20M | 206.74M | Total Assets |
529.12M | 529.12M | 537.74M | 602.34M | 447.25M | 433.19M | Total Debt |
110.87M | 110.87M | 90.64M | 124.14M | 108.31M | 131.29M | Net Debt |
-187.78M | -187.78M | -195.80M | -206.09M | -118.89M | -75.44M | Total Liabilities |
299.15M | 299.15M | 305.78M | 358.45M | 311.56M | 304.82M | Stockholders Equity |
229.96M | 229.96M | 231.96M | 232.17M | 135.69M | 128.37M |
Cash Flow | Free Cash Flow | ||||
7.06M | 2.25M | 22.95M | 42.63M | 46.16M | 24.19M | Operating Cash Flow |
7.75M | 2.92M | 24.38M | 51.69M | 48.47M | 26.85M | Investing Cash Flow |
-256.36M | 6.71M | 10.27M | -64.05M | 2.65M | 2.56M | Financing Cash Flow |
40.11M | 18.51M | -59.46M | 105.41M | -48.04M | -5.74M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $77.64B | 19.18 | 26.55% | 2.21% | -1.69% | 17.32% | |
72 Outperform | HK$107.47M | 4.76 | 15.81% | ― | -23.34% | 57.93% | |
64 Neutral | HK$4.85B | 16.36 | 4.74% | 6.76% | -26.12% | -75.34% | |
63 Neutral | $4.28B | 11.33 | 5.43% | 214.88% | 4.12% | -8.65% | |
60 Neutral | $8.98B | 6.81 | 4.75% | 5.62% | 4.24% | 25.30% | |
50 Neutral | HK$1.74B | 11.68 | 4.99% | 9.60% | 10.66% | 3.88% |